Workshop Overview for Oligonucleotide Therapeutics and Delivery 2020
SMi reports: Workshop Overview for the Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on September 15, 2020 one day before the conference taking place on September 16 and 17.
London, United Kingdom, April 29, 2020 --(PR.com)-- Established on the success of their RNA Therapeutics series, SMi look forward to welcoming delegates at Oligonucleotide Therapeutics and Delivery to join the conversation around maximizing the potential of oligo-based treatments.
Which includes an interactive half day pre-conference workshop taking place from 1pm – 5pm in London on the 15th of September 2020.
Workshop overview:
Oligonucleotide drug discovery: Target selection, delivery, molecular design and lead identification
Workshop Leaders:
Troels Koch, Chief Technology Officer, SVP Science and Technology, Inexos Therapeutics
Maj Hedtjärn, SVP Discovery & Pre-Clinical Development, Inexos Therapeutics
Short Summary about the Workshop Leaders:
Troels Koch (TK) has 20 years’ experience in the international life science and biopharmaceutical industry. Founder of several biotech companies.
Maj Hedtjärn is an experienced leader in the field of RNA Therapeutics Drug Discovery, Research and Innovation with more than 14 years of R&D experience from biotech and big pharma and more than 10 years of leadership experience.
This workshop will focus on the initial parameters for drug discovery. It is intended that the workshop is interactive so detailed discussions between the presenters and the audience is enticed.
To learn more about the conference and workshop visit the SMi website and download the brochure. There is also an early bird saving of £600 will be applied to bookings made before April 30, 2020: http://www.oligonucleotide.co.uk/prcom2
Why you should attend:
- Gain insight into the complex drug discovery process of oligonucleotide-based therapeutics from project start to finish
- Listen to case studies revealing crucial aspects of delivery and how to tackle delivery related challenges
- Deep dive into in silico structure-based molecular modelling of oligonucleotides
- Develop the right controls for in vivo and in vitro assays for securing high translation rates
The event brochure with the workshop agenda and speaker line-up is available to download from the website; those interested in attending can register at: http://www.oligonucleotide.co.uk/prcom2
Oligonucleotide Therapeutics and Delivery
Main conference: 16-17 September 2020
London, UK
For media queries please contact Jinna Sidhu at hsidhu@smi-online.co.uk or call +44 (0)20 7827 6088
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Which includes an interactive half day pre-conference workshop taking place from 1pm – 5pm in London on the 15th of September 2020.
Workshop overview:
Oligonucleotide drug discovery: Target selection, delivery, molecular design and lead identification
Workshop Leaders:
Troels Koch, Chief Technology Officer, SVP Science and Technology, Inexos Therapeutics
Maj Hedtjärn, SVP Discovery & Pre-Clinical Development, Inexos Therapeutics
Short Summary about the Workshop Leaders:
Troels Koch (TK) has 20 years’ experience in the international life science and biopharmaceutical industry. Founder of several biotech companies.
Maj Hedtjärn is an experienced leader in the field of RNA Therapeutics Drug Discovery, Research and Innovation with more than 14 years of R&D experience from biotech and big pharma and more than 10 years of leadership experience.
This workshop will focus on the initial parameters for drug discovery. It is intended that the workshop is interactive so detailed discussions between the presenters and the audience is enticed.
To learn more about the conference and workshop visit the SMi website and download the brochure. There is also an early bird saving of £600 will be applied to bookings made before April 30, 2020: http://www.oligonucleotide.co.uk/prcom2
Why you should attend:
- Gain insight into the complex drug discovery process of oligonucleotide-based therapeutics from project start to finish
- Listen to case studies revealing crucial aspects of delivery and how to tackle delivery related challenges
- Deep dive into in silico structure-based molecular modelling of oligonucleotides
- Develop the right controls for in vivo and in vitro assays for securing high translation rates
The event brochure with the workshop agenda and speaker line-up is available to download from the website; those interested in attending can register at: http://www.oligonucleotide.co.uk/prcom2
Oligonucleotide Therapeutics and Delivery
Main conference: 16-17 September 2020
London, UK
For media queries please contact Jinna Sidhu at hsidhu@smi-online.co.uk or call +44 (0)20 7827 6088
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Jinna Sidhu
+44 (0) 20 7827 6088
http://www.oligonucleotide.co.uk/prcom2
Jinna Sidhu
+44 (0) 20 7827 6088
http://www.oligonucleotide.co.uk/prcom2
Contact
Categories